105 related articles for article (PubMed ID: 6395057)
21. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
[TBL] [Abstract][Full Text] [Related]
22. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
23. T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation.
Verlinden SF; Mulder AH; de Leeuw JP; van Bekkum DW
Stem Cells; 1998; 16 Suppl 1():205-17. PubMed ID: 11012164
[TBL] [Abstract][Full Text] [Related]
24. Differential sensitivity of T lymphocytes and hematopoietic precursor cells to photochemotherapy with 8-methoxypsoralen and ultraviolet A light.
Mabed M; Coffe C; Racadot E; Angonin R; Pavey JJ; Tiberghien P; Herve P
Ann Hematol; 2006 Jan; 85(1):17-24. PubMed ID: 16208471
[TBL] [Abstract][Full Text] [Related]
25. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
[TBL] [Abstract][Full Text] [Related]
26. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.
Hamilton BL; Bevan MJ; Parkman R
J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo culture rescues hematopoietic stem cells with long-term repopulating capacity following harvest from lethally irradiated mice.
Chute JP; Fung J; Muramoto G; Erwin R
Exp Hematol; 2004 Mar; 32(3):308-17. PubMed ID: 15003317
[TBL] [Abstract][Full Text] [Related]
28. [Change in stem-cell differentiation from erythroid type to myeloid type due to lymphocytes].
Petrov RV; Shvets VN; Man'ko VM
Dokl Akad Nauk SSSR; 1972 May; 204(2):489-92. PubMed ID: 4557914
[No Abstract] [Full Text] [Related]
29. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
Johnson BD; Drobyski WR; Truitt RL
Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
[TBL] [Abstract][Full Text] [Related]
30. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting immune responsiveness in vitro of germfree allogeneic radiation chimeras. I. Differences between donor and host strains.
Beardsley TR; Bealmear PM; Mirand EA; Holtermann OA
Prog Clin Biol Res; 1983; 132C():433-50. PubMed ID: 6356144
[TBL] [Abstract][Full Text] [Related]
32. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
33. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
34. Rapid lethality of hosts by interleukin-12 following H-2 compatible allogeneic bone marrow transplantation: Reminiscence of gut-associated acute graft-versus-host reaction.
Schmitt M; Taniguchi M; Yoshida T; Miyahara Y; Gu X; Mukai K; Yagita H; Dohner H; Shiku H
Int J Oncol; 2002 Oct; 21(4):795-801. PubMed ID: 12239618
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of intrathymic B cells in normal and chimera mice.
Wang B
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):496-506. PubMed ID: 8340047
[TBL] [Abstract][Full Text] [Related]
36. Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice.
Wang L; Cui Y; Lord BI; Roberts SA; Potten CS; Hendry JH; Scott D
Radiat Res; 1996 Sep; 146(3):259-66. PubMed ID: 8752303
[TBL] [Abstract][Full Text] [Related]
37. Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI).
Slavin S; Seidel HJ
Exp Hematol; 1982 Feb; 10(2):206-16. PubMed ID: 7037437
[TBL] [Abstract][Full Text] [Related]
38. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
39. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
Shizuru JA; Jerabek L; Edwards CT; Weissman IL
Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
[TBL] [Abstract][Full Text] [Related]
40. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
